APDA’s New Program to “PRESS” Forward with Support/Information

Posted on by Phil Franchina

Parkinson’s Roadmap for Education and Support Services (PRESS) is an eight week in-person support series with tailored content to...see more address the psychosocial needs of those who have been diagnosed within the last five years. Each PRESS support group is facilitated by a trained healthcare professional and will provide a structured platform for people to share […]

Read More

Fundraisers Walk to Make an Impact

Posted on by Phil Franchina

APDA’s Optimism Walks bring friends and families together in support of those living with Parkinson’s, mobilizing communities to put...see more an end to this disease, together. See how some participants have gone above and beyond in their fundraising efforts. Team: Porter’s Supporters Team Captain: Steve Porter Total raised: $1,635 When Steve Porter learned that he had […]

Read More

APDA Grantees Investigate New PD Treatment Option

Posted on by Phil Franchina

Alice Cronin-Golomb, PhD, at the Boston University School of Medicine, one of the 15 APDA grant recipients for the 2017-2018...see more academic year, is leading a team of investigators to create solutions for people with PD. Their objective is to develop a low-cost treatment to improve cognitive and gait function without causing negative side effects.  The inspiration […]

Read More

$1.5 Million in Research Grants Awarded for 2017 – 2018 Academic Year

Posted on by Phil Franchina

APDA is pleased to announce that $1.5 million in research grant funding has been awarded to support cutting-edge Parkinson’s...see more disease (PD) research via four Post-Doctoral Fellowships, 11 Research Grants, and eight APDA Centers of Advanced Research as part of its 2017-2018 funding cycle. The grants are awarded through a competitive application process and reviewed by […]

Read More

EXCITING PARKINSON’S DISEASE TREATMENT NEWS

Posted on by Phil Franchina

New York, NY, August 28, 2017 – The American Parkinson Disease Association is pleased to share with the Parkinson’s...see more community the arrival of a new medication in the treatment arsenal to address Parkinson’s symptoms. Approved August 24 by the U.S. Food and Drug Administration is GOCOVRI™ (amantadine) developed by Adamas.  GOCOVRI is an extended release […]

Read More

APDA Awards $1.5 Million in Research Grants

Posted on by Phil Franchina

NEW YORK, NY – August 16, 2017 – The American Parkinson Disease Association (APDA) has awarded $1.5 million to...see more support cutting-edge Parkinson’s disease (PD) research via four Post-Doctoral Fellowships, 11 Research Grants, and eight APDA Centers of Advanced Research as part of its 2017-2018 funding cycle. With someone diagnosed with PD every nine minutes, this […]

Read More

APDA Scientific Advisory Board (SAB) Meets to Determine 2017-2018 Research Funding

Posted on by Phil Franchina

NEW YORK, NY, May 26, 2017 – The American Parkinson Disease Association’s Scientific Advisory Board (SAB) met this week...see more to review more than eighty-nine grant submissions all vying for nearly $1,000,000 in funding that will be awarded to both experienced and emerging young scientists in the Parkinson’s field. The American Parkinson Disease Association (APDA) is […]

Read More

Launches Online Parkinson’s Support for People with Parkinson’s and Care Partners

Posted on by Phil Franchina

APDA partners with Smart Patients to build new online community that will give patients and families access to support...see more and to learn from one another. NEW YORK, NY, May 16, 2017 – The American Parkinson Disease Association (APDA) announces today a collaboration with Smart Patients, an online support site for patients and caregivers, to create […]

Read More